Tung T Wynn, MD

This is a prospective, observational, multi-center longitudinal cohort study to describe the real-world effectiveness, safety and treatment usage of efanesoctocog alfa in patients with hemophilia A treated per standard of care in the US and…

Investigator

Tung T Wynn

Status

Accepting Candidates

Ages

N/A - N/A

Sexes

All

Investigator

Tung T Wynn

Status

Accepting Candidates

Pediatric cancer survivors are at an increased risk of excessive weight gain and reduced exercise behaviors with the potential for this risk to worsen over time. With over 80% of pediatric cancer patients living to adulthood, many pediatric cancer…

Investigator

Tung T Wynn

Status

Accepting Candidates

Ages

5 Years - 14 Years

Sexes

All